Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Ophthalmology
|
October 23, 2019
Reply
Peter A Campochiaro, Katie F Maass, Natasha Singh, et al.
The AAPS Journal
|
February 26, 2016
Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
Katie F Maass, Chethana Kulkarni, Alison M Betts, et al.
Journal of Applied Polymer Science
|
September 26, 2015
Dynamic swelling behavior of interpenetrating polymer networks in response to temperature and pH
Brandon V Slaughter, Aaron T Blanchard, Katie F Maass, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 6, 2022
In-vitro characterization of ranibizumab release from the Port Delivery System
Stefan Yohe, Katie F Maass, Judit Horvath, et al.
Nature Medicine
|
November 24, 2020
Will patient-centric sampling become the norm for clinical trials after COVID-19?
Christopher A James, Matthew D Barfield, Katie F Maass, et al.
Journal of Pharmaceutical Sciences
|
September 8, 2015
A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin
Katie F Maass, Chethana Kulkarni, Mohiuddin A Quadir, et al.
Molecular Pharmaceutics
|
December 27, 2019
Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction
Antonello Caruso, Matthias Füth, Ruben Alvarez-Sánchez, et al.
Ophthalmology. Retina
|
October 24, 2024
Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections
Veeral S Sheth, Nancy M Holekamp, Arshad M Khanani, et al.
The AAPS Journal
|
April 1, 2016
Evolution of Antibody-Drug Conjugate Tumor Disposition Model to Predict Preclinical Tumor Pharmacokinetics of Trastuzumab-Emtansine (T-DM1)
Aman P Singh, Katie F Maass, Alison M Betts, et al.
Ophthalmology and Therapy
|
June 27, 2022
Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration
Charles C Wykoff, Peter A Campochiaro, Dante J Pieramici, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Ophthalmology
|
October 23, 2019
Reply
Peter A Campochiaro, Katie F Maass, Natasha Singh, et al.
The AAPS Journal
|
February 26, 2016
Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
Katie F Maass, Chethana Kulkarni, Alison M Betts, et al.
Journal of Applied Polymer Science
|
September 26, 2015
Dynamic swelling behavior of interpenetrating polymer networks in response to temperature and pH
Brandon V Slaughter, Aaron T Blanchard, Katie F Maass, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 6, 2022
In-vitro characterization of ranibizumab release from the Port Delivery System
Stefan Yohe, Katie F Maass, Judit Horvath, et al.
Nature Medicine
|
November 24, 2020
Will patient-centric sampling become the norm for clinical trials after COVID-19?
Christopher A James, Matthew D Barfield, Katie F Maass, et al.
Journal of Pharmaceutical Sciences
|
September 8, 2015
A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin
Katie F Maass, Chethana Kulkarni, Mohiuddin A Quadir, et al.
Molecular Pharmaceutics
|
December 27, 2019
Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction
Antonello Caruso, Matthias Füth, Ruben Alvarez-Sánchez, et al.
Ophthalmology. Retina
|
October 24, 2024
Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections
Veeral S Sheth, Nancy M Holekamp, Arshad M Khanani, et al.
The AAPS Journal
|
April 1, 2016
Evolution of Antibody-Drug Conjugate Tumor Disposition Model to Predict Preclinical Tumor Pharmacokinetics of Trastuzumab-Emtansine (T-DM1)
Aman P Singh, Katie F Maass, Alison M Betts, et al.
Ophthalmology and Therapy
|
June 27, 2022
Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration
Charles C Wykoff, Peter A Campochiaro, Dante J Pieramici, et al.
Page
of 2